Comparative Outcomes and Toxicities for Ruthenium-106 versus Palladium-103 in the Treatment of Choroidal Melanoma

PURPOSE: For treatment of choroidal melanoma, Palladium-103 ((103)Pd) and Ruthenium-106 ((106)Ru) plaque brachytherapy demonstrates reduced toxicity compared to the historical standard Iodine-125 ((125)I). No report has directly compared clinical outcomes between (103)Pd and (106)Ru, and reasons for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Melanoma Res
Main Authors: Danish, Hasan, Ferris, Matthew J., Balagamwala, Ehsan, Switchenko, Jeffrey, Patel, Kirtesh, Choudhary, Maria, Craven, Caroline, Mendoza, Pia, Suh, John, Bergstrom, Chris, Grossniklaus, Hans E., Aaberg, Thomas, Singh, Arun, Crocker, Ian, Khan, Mohammad K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828969/
https://ncbi.nlm.nih.gov/pubmed/29303890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000420
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados